The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nuclear Cardiology Market Research Report 2025
Synopsis
Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
The global Nuclear Cardiology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.
This report aims to provide a comprehensive presentation of the global market for Nuclear Cardiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Cardiology.
Report Scope
The Nuclear Cardiology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Cardiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Cardiology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Shimadzu
Siemens Healthcare
Fujifilm Medical
Astellas Pharma
Philips Healthcare
Medtronic
3mensio Medical Imaging
Bracco Diagnostics
UltraSPECT
Segment by Type
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
Segment by Application
Hospitals
Clinics
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Cardiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
The global Nuclear Cardiology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.
This report aims to provide a comprehensive presentation of the global market for Nuclear Cardiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Cardiology.
Report Scope
The Nuclear Cardiology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Cardiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Cardiology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Shimadzu
Siemens Healthcare
Fujifilm Medical
Astellas Pharma
Philips Healthcare
Medtronic
3mensio Medical Imaging
Bracco Diagnostics
UltraSPECT
Segment by Type
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
Segment by Application
Hospitals
Clinics
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Cardiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Cardiology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radiology Devices
1.2.3 Radiology Information Systems (RIS)
1.2.4 Radiopharmaceuticals
1.3 Market by Application
1.3.1 Global Nuclear Cardiology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Cardiology Market Perspective (2019-2030)
2.2 Nuclear Cardiology Growth Trends by Region
2.2.1 Global Nuclear Cardiology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nuclear Cardiology Historic Market Size by Region (2019-2024)
2.2.3 Nuclear Cardiology Forecasted Market Size by Region (2025-2030)
2.3 Nuclear Cardiology Market Dynamics
2.3.1 Nuclear Cardiology Industry Trends
2.3.2 Nuclear Cardiology Market Drivers
2.3.3 Nuclear Cardiology Market Challenges
2.3.4 Nuclear Cardiology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Cardiology Players by Revenue
3.1.1 Global Top Nuclear Cardiology Players by Revenue (2019-2024)
3.1.2 Global Nuclear Cardiology Revenue Market Share by Players (2019-2024)
3.2 Global Nuclear Cardiology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclear Cardiology Revenue
3.4 Global Nuclear Cardiology Market Concentration Ratio
3.4.1 Global Nuclear Cardiology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Cardiology Revenue in 2023
3.5 Nuclear Cardiology Key Players Head office and Area Served
3.6 Key Players Nuclear Cardiology Product Solution and Service
3.7 Date of Enter into Nuclear Cardiology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Cardiology Breakdown Data by Type
4.1 Global Nuclear Cardiology Historic Market Size by Type (2019-2024)
4.2 Global Nuclear Cardiology Forecasted Market Size by Type (2025-2030)
5 Nuclear Cardiology Breakdown Data by Application
5.1 Global Nuclear Cardiology Historic Market Size by Application (2019-2024)
5.2 Global Nuclear Cardiology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nuclear Cardiology Market Size (2019-2030)
6.2 North America Nuclear Cardiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nuclear Cardiology Market Size by Country (2019-2024)
6.4 North America Nuclear Cardiology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Cardiology Market Size (2019-2030)
7.2 Europe Nuclear Cardiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nuclear Cardiology Market Size by Country (2019-2024)
7.4 Europe Nuclear Cardiology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Cardiology Market Size (2019-2030)
8.2 Asia-Pacific Nuclear Cardiology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nuclear Cardiology Market Size by Region (2019-2024)
8.4 Asia-Pacific Nuclear Cardiology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Cardiology Market Size (2019-2030)
9.2 Latin America Nuclear Cardiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nuclear Cardiology Market Size by Country (2019-2024)
9.4 Latin America Nuclear Cardiology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Cardiology Market Size (2019-2030)
10.2 Middle East & Africa Nuclear Cardiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nuclear Cardiology Market Size by Country (2019-2024)
10.4 Middle East & Africa Nuclear Cardiology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Cardiology Introduction
11.1.4 GE Healthcare Revenue in Nuclear Cardiology Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Shimadzu
11.2.1 Shimadzu Company Detail
11.2.2 Shimadzu Business Overview
11.2.3 Shimadzu Nuclear Cardiology Introduction
11.2.4 Shimadzu Revenue in Nuclear Cardiology Business (2019-2024)
11.2.5 Shimadzu Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Detail
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Nuclear Cardiology Introduction
11.3.4 Siemens Healthcare Revenue in Nuclear Cardiology Business (2019-2024)
11.3.5 Siemens Healthcare Recent Development
11.4 Fujifilm Medical
11.4.1 Fujifilm Medical Company Detail
11.4.2 Fujifilm Medical Business Overview
11.4.3 Fujifilm Medical Nuclear Cardiology Introduction
11.4.4 Fujifilm Medical Revenue in Nuclear Cardiology Business (2019-2024)
11.4.5 Fujifilm Medical Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Detail
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Nuclear Cardiology Introduction
11.5.4 Astellas Pharma Revenue in Nuclear Cardiology Business (2019-2024)
11.5.5 Astellas Pharma Recent Development
11.6 Philips Healthcare
11.6.1 Philips Healthcare Company Detail
11.6.2 Philips Healthcare Business Overview
11.6.3 Philips Healthcare Nuclear Cardiology Introduction
11.6.4 Philips Healthcare Revenue in Nuclear Cardiology Business (2019-2024)
11.6.5 Philips Healthcare Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Detail
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Nuclear Cardiology Introduction
11.7.4 Medtronic Revenue in Nuclear Cardiology Business (2019-2024)
11.7.5 Medtronic Recent Development
11.8 3mensio Medical Imaging
11.8.1 3mensio Medical Imaging Company Detail
11.8.2 3mensio Medical Imaging Business Overview
11.8.3 3mensio Medical Imaging Nuclear Cardiology Introduction
11.8.4 3mensio Medical Imaging Revenue in Nuclear Cardiology Business (2019-2024)
11.8.5 3mensio Medical Imaging Recent Development
11.9 Bracco Diagnostics
11.9.1 Bracco Diagnostics Company Detail
11.9.2 Bracco Diagnostics Business Overview
11.9.3 Bracco Diagnostics Nuclear Cardiology Introduction
11.9.4 Bracco Diagnostics Revenue in Nuclear Cardiology Business (2019-2024)
11.9.5 Bracco Diagnostics Recent Development
11.10 UltraSPECT
11.10.1 UltraSPECT Company Detail
11.10.2 UltraSPECT Business Overview
11.10.3 UltraSPECT Nuclear Cardiology Introduction
11.10.4 UltraSPECT Revenue in Nuclear Cardiology Business (2019-2024)
11.10.5 UltraSPECT Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nuclear Cardiology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Radiology Devices
Table 3. Key Players of Radiology Information Systems (RIS)
Table 4. Key Players of Radiopharmaceuticals
Table 5. Global Nuclear Cardiology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Nuclear Cardiology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Nuclear Cardiology Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Nuclear Cardiology Market Share by Region (2019-2024)
Table 9. Global Nuclear Cardiology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Nuclear Cardiology Market Share by Region (2025-2030)
Table 11. Nuclear Cardiology Market Trends
Table 12. Nuclear Cardiology Market Drivers
Table 13. Nuclear Cardiology Market Challenges
Table 14. Nuclear Cardiology Market Restraints
Table 15. Global Nuclear Cardiology Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Nuclear Cardiology Market Share by Players (2019-2024)
Table 17. Global Top Nuclear Cardiology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Cardiology as of 2023)
Table 18. Ranking of Global Top Nuclear Cardiology Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Nuclear Cardiology Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nuclear Cardiology Product Solution and Service
Table 22. Date of Enter into Nuclear Cardiology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nuclear Cardiology Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Nuclear Cardiology Revenue Market Share by Type (2019-2024)
Table 26. Global Nuclear Cardiology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Nuclear Cardiology Revenue Market Share by Type (2025-2030)
Table 28. Global Nuclear Cardiology Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Nuclear Cardiology Revenue Market Share by Application (2019-2024)
Table 30. Global Nuclear Cardiology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Nuclear Cardiology Revenue Market Share by Application (2025-2030)
Table 32. North America Nuclear Cardiology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Nuclear Cardiology Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Nuclear Cardiology Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Nuclear Cardiology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Nuclear Cardiology Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Nuclear Cardiology Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Nuclear Cardiology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Nuclear Cardiology Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Nuclear Cardiology Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Nuclear Cardiology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Nuclear Cardiology Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Nuclear Cardiology Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Nuclear Cardiology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Nuclear Cardiology Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Nuclear Cardiology Market Size by Country (2025-2030) & (US$ Million)
Table 47. GE Healthcare Company Detail
Table 48. GE Healthcare Business Overview
Table 49. GE Healthcare Nuclear Cardiology Product
Table 50. GE Healthcare Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 51. GE Healthcare Recent Development
Table 52. Shimadzu Company Detail
Table 53. Shimadzu Business Overview
Table 54. Shimadzu Nuclear Cardiology Product
Table 55. Shimadzu Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 56. Shimadzu Recent Development
Table 57. Siemens Healthcare Company Detail
Table 58. Siemens Healthcare Business Overview
Table 59. Siemens Healthcare Nuclear Cardiology Product
Table 60. Siemens Healthcare Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 61. Siemens Healthcare Recent Development
Table 62. Fujifilm Medical Company Detail
Table 63. Fujifilm Medical Business Overview
Table 64. Fujifilm Medical Nuclear Cardiology Product
Table 65. Fujifilm Medical Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 66. Fujifilm Medical Recent Development
Table 67. Astellas Pharma Company Detail
Table 68. Astellas Pharma Business Overview
Table 69. Astellas Pharma Nuclear Cardiology Product
Table 70. Astellas Pharma Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 71. Astellas Pharma Recent Development
Table 72. Philips Healthcare Company Detail
Table 73. Philips Healthcare Business Overview
Table 74. Philips Healthcare Nuclear Cardiology Product
Table 75. Philips Healthcare Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 76. Philips Healthcare Recent Development
Table 77. Medtronic Company Detail
Table 78. Medtronic Business Overview
Table 79. Medtronic Nuclear Cardiology Product
Table 80. Medtronic Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 81. Medtronic Recent Development
Table 82. 3mensio Medical Imaging Company Detail
Table 83. 3mensio Medical Imaging Business Overview
Table 84. 3mensio Medical Imaging Nuclear Cardiology Product
Table 85. 3mensio Medical Imaging Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 86. 3mensio Medical Imaging Recent Development
Table 87. Bracco Diagnostics Company Detail
Table 88. Bracco Diagnostics Business Overview
Table 89. Bracco Diagnostics Nuclear Cardiology Product
Table 90. Bracco Diagnostics Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 91. Bracco Diagnostics Recent Development
Table 92. UltraSPECT Company Detail
Table 93. UltraSPECT Business Overview
Table 94. UltraSPECT Nuclear Cardiology Product
Table 95. UltraSPECT Revenue in Nuclear Cardiology Business (2019-2024) & (US$ Million)
Table 96. UltraSPECT Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Cardiology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nuclear Cardiology Market Share by Type: 2023 VS 2030
Figure 3. Radiology Devices Features
Figure 4. Radiology Information Systems (RIS) Features
Figure 5. Radiopharmaceuticals Features
Figure 6. Global Nuclear Cardiology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Nuclear Cardiology Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Academic and Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Nuclear Cardiology Report Years Considered
Figure 13. Global Nuclear Cardiology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Nuclear Cardiology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Nuclear Cardiology Market Share by Region: 2023 VS 2030
Figure 16. Global Nuclear Cardiology Market Share by Players in 2023
Figure 17. Global Top Nuclear Cardiology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Cardiology as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Cardiology Revenue in 2023
Figure 19. North America Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Nuclear Cardiology Market Share by Country (2019-2030)
Figure 21. United States Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Nuclear Cardiology Market Share by Country (2019-2030)
Figure 25. Germany Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Nuclear Cardiology Market Share by Region (2019-2030)
Figure 33. China Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Nuclear Cardiology Market Share by Country (2019-2030)
Figure 41. Mexico Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Nuclear Cardiology Market Share by Country (2019-2030)
Figure 45. Turkey Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Nuclear Cardiology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. GE Healthcare Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 48. Shimadzu Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 49. Siemens Healthcare Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 50. Fujifilm Medical Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 51. Astellas Pharma Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 52. Philips Healthcare Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 53. Medtronic Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 54. 3mensio Medical Imaging Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 55. Bracco Diagnostics Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 56. UltraSPECT Revenue Growth Rate in Nuclear Cardiology Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
